Skip to main content
. 2021 Dec 13;12:736860. doi: 10.3389/fphar.2021.736860

FIGURE 2.

FIGURE 2

Tornado diagrams showing the effect of lower and upper values of each parameter on the ICERs of the nivolumab-plus-cabozantinib versus sunitinib strategy.